Birinapant 是一种二价 Smac 类似物,为
XIAP 和
cIAP1的有效拮抗剂,
Kd 值分别为 45 nM 和 < 1 nM。
Birinapant产品描述:Birinapant a bivalent Smac mimetic, is a potent antago
nist for
XIAP and
cIAP1 with
Kd values of 45 nM and < 1 nM, respectively.
In Vitro: Birinapant causes significant degradation of cIAP1 and 2. Birinapant +
TRAIL-treated cells show increased levels of active caspase-8 and
caspase-3, as well as PARP cleavage, over single agents within 4 h of
treatment, indicative of apoptosis-mediated cell death. Birinapan
significantly decreases the viability of SUM190 cells in a
dose-dependent manner. Birinapant treatment in the XIAP knockdown cell
line (SUM190 shXIAP) causes an overall reduction in viability at lower
doses (30-300 nM)
[1].
Birinapant causes apoptosis in the sensitive cells. Birinapant in
co
nbination with TNF-α, causes PARP cleavage in 451Lu and WM1366 cell
lines
[2].
Birinapant induces time-course of caspase-3 activation in HCT116 human
co
lon carcinoma and MDA-MB-231 human breast adenocarcinoma cells
[3].
In Vivo: Birinapant can inhibit tumor growth in melanoma xenotransplantation
models. Staining for activated caspase-3 in biopsies of the same tumors
show a modest increase in apoptotic cells in the birinapant treated
animals
[2]. Birinapant (15 mg/kg, i.p.) induces apoptosis in HCT116 tumor-bearing mouse
[3].
公司介绍:MedChemExpress(MCE)专注于各种抑制剂、激动剂、API及化合物库,总部位于美国新泽西,分别在瑞典和上海设有欧洲区子公司和区总代理,营销网点遍及20多个地区。MCE经过多年努力已成为生物活性小分子领域的供应商,
产品涵盖癌症、神经科学、抗感染、表观遗传学等20个热门研究领域,PI3K、MAPK等近千个细分靶点,超过4000个活性小分子化合物现货,以及GPCR、API、离子通道等超过20种不同类型的化合物库,同时提供从毫克到千克的专业定制合成服务。
MCE 对每批产品都进行严格的LCMS和NMR检验,其产品已被近万名客户广泛使用并发表大量文章、;
MCE 定期增加各领域热门抑制剂、激动剂,不断扩增已有化合物库,以满足新的科研需求;
数千种产品在上海有充足备货,24-48小时内送达客户;
大量产品提供试用装; 已为多个知名企业、院校构建各种定制型化合物库。
Purity:98%
MWt:806.9409
Formula:C42H56F2N8O6
SMILES:FC1=CC2=C(C=C1)C(C[C@H]3N(C([C@@H](NC([C@@H](NC)C)=O)CC)=O)C[C@@H](O)C3)=C(C(N4)=C(C[C@H]5N(C([C@@H](NC([C@@H](NC)C)=O)CC)=O)C[C@@H](O)C5)C6=C4C=C(F)C=C6)N2
Pathway:Apoptosis;
Mechanisms:IAP;
Research Area:Cancer
本页产品地址:http://www.geilan.com/sell/show-8005594.html